|
ACUG
MCID: BLS001
|
Blau Syndrome malady |
|
4 drugs, 14 genes, 2 tissues, 536 related diseases, 2 phenotypes, 26 articles, clinical trials, genetic tests.
|
|
|
Sources: 17Genetics Home Reference, 30NIH Rare Diseases, 44Wikipedia, 33OMIM, 22MalaCards See all sources Export this MalaCard |
NIH Rare Diseases: Blau syndrome is a rare condition characterized mainly by skin rash, arthritis and uveitis. It has variable expressivity and usually affects preschool age children younger than four years of age. Characteristic findings include synovial effusions (fluid in the joints due to inflammation) and cysts, anterior uveitis (swelling and irritation of the uvea) and focal posterior synechiae (adhesion of the iris to the cornea). Permanent bending of the fingers and toes (camptodactyly) and other findings have also been reported. It is caused by mutations in the NOD2 gene and is inherited in an autosomal dominant manner. Blau syndrome and early-onset sarcoidosis have the same symptoms and genetic cause, but early-onset sarcoidosis is caused by de novo (new) mutations and occurs sporadically (in individuals with no history of the disorder in the family).30
MalaCards: Blau Syndrome, also known as arthrocutaneouveal granulomatosis, is related to rheumatoid arthritis and pulmonary sarcoidosis. An important gene associated with Blau Syndrome is NOD2 (nucleotide-binding oligomerization domain containing 2), and among its related pathways are RAR-Gamma-RXR-Alpha Degradation and Cytokine Network. The drugs meclofenamate sodium and meclofenamate and the compounds leflunomide and ionomycin have been mentioned in the context of this disorder. Affiliated tissues include skin and t cells, and related mouse phenotypes are immune system and skeleton. Genetics Home Reference: Blau syndrome is an inflammatory disorder that primarily affects the skin, joints, and eyes. Signs and symptoms begin in childhood, usually before age 4.17 Wikipedia: Blau syndrome is characterized by familial granulomatous arthritis, uvitis, and skin granulomas,...44 more... OMIM: 186580 |
|
Sources: 6Disease Ontology, 7diseasecard, 30NIH Rare Diseases, 16GeneTests, 17Genetics Home Reference, 8DISEASES, 33OMIM, 32Novoseek , 43UMLS See all sources |
Aliases & Descriptions:
|
|
Sources: 33OMIM See all sources |
Clinical features from OMIM: 186580
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for blau syndrome Drug clinical trials:Search ClinicalTrials for blau syndrome Search NIH Clinical Center for blau syndrome Search CenterWatch for blau syndrome Inferred drug relations via UMLS/NDF-RT:43 28 devils claw, meclofenamate, meclofenamate sodium, salsalate |
|
Sources: 16GeneTests See all sources |
|
Sources: 22MalaCards See all sources |
MalaCards organs/tissues related to blau syndrome:22Skin, T cells
|
|
Sources: 25MGI See all sources |
|
Sources: 35PubMed See all sources |
Articles related to blau syndrome:(show all 26)
|
|
Sources: 1BioGPS See all sources |
![]() |
|
Sources: 36QIAGEN, 37R&D Systems, 20KEGG, 3Cell Signaling Technology, 38Reactome See all sources |
Pathways related to blau syndrome according to GeneDecks:(show all 27)
|
|
Sources: 32Novoseek , 9DrugBank, 42Tocris Bioscience, 34PharmGKB, 18HMDB See all sources |
Compounds related to blau syndrome according to GeneDecks:(show top 50) (show all 76)
|
|
Sources: 12Gene Ontology See all sources |
Biological processes related to blau syndrome according to GeneDecks:(show all 38)
Molecular functions related to blau syndrome according to GeneDecks:
|
